Pieris Pharmaceuticals, Inc. (PIRS): Price and Financial Metrics


Pieris Pharmaceuticals, Inc. (PIRS)

Today's Latest Price: $2.93 USD

0.11 (3.90%)

Updated Nov 24 4:00pm

Add PIRS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

PIRS Stock Summary

  • Of note is the ratio of Pieris Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; just 13.64% of US stocks have a lower such ratio.
  • As for revenue growth, note that PIRS's revenue has grown 31.82% over the past 12 months; that beats the revenue growth of 85.17% of US companies in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for PIRS comes in at -26.8% -- higher than that of just 12.88% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Pieris Pharmaceuticals Inc, a group of peers worth examining would be EVGN, KALV, WVE, SYBX, and DTIL.
  • Visit PIRS's SEC page to see the company's official filings. To visit the company's web site, go to www.pieris.com.

PIRS Stock Price Chart Interactive Chart >

Price chart for PIRS

PIRS Price/Volume Stats

Current price $2.93 52-week high $4.30
Prev. close $2.82 52-week low $1.60
Day low $2.78 Volume 357,900
Day high $3.00 Avg. volume 454,258
50-day MA $2.44 Dividend yield N/A
200-day MA $2.79 Market Cap 164.00M

Pieris Pharmaceuticals, Inc. (PIRS) Company Bio


Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops Anticalin-based drugs. The company develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. The company is based in Boston, Massachusetts.


PIRS Latest News Stream


Event/Time News Detail
Loading, please wait...

PIRS Latest Social Stream


Loading social stream, please wait...

View Full PIRS Social Stream

Latest PIRS News From Around the Web

Below are the latest news stories about Pieris Pharmaceuticals Inc that investors may wish to consider to help them evaluate PIRS as an investment opportunity.

Here's What Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Shareholder Ownership Structure Looks Like

The big shareholder groups in Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) have power over the company. Insiders often…

Yahoo Finance | September 28, 2020

Recap: Pieris Pharmaceuticals Q2 Earnings

Shares of Pieris Pharmaceuticals (NASDAQ:PIRS) rose 8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share …

Benzinga | August 10, 2020

Pieris Pharmaceuticals Announces Oral Presentation of Phase 1 Data for 4-1BB/HER2 Bispecific PRS-343 at European Society for Medical Oncology (ESMO) Virtual Congress 2020

BOSTON, MA / ACCESSWIRE / July 23, 2020 / Pieris Pharmaceuticals, Inc.

Yahoo | July 23, 2020

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Pieris Pharmaceuticals, Inc. (PIRS) Investigation

NEW YORK, NY / ACCESSWIRE / July 22, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pieris Pharmaceuticals, Inc.

Yahoo | July 22, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pieris Pharmaceuticals, Inc. - PIRS

Pomerantz LLP is investigating claims on behalf of investors Pieris Pharmaceuticals, Inc. ("Pieris" or the "Company") (NASDAQ: PIRS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Yahoo | July 21, 2020

Read More 'PIRS' Stories Here

PIRS Price Returns

1-mo 30.22%
3-mo 0.00%
6-mo -9.01%
1-year -26.20%
3-year -54.92%
5-year 18.15%
YTD -19.06%
2019 36.09%
2018 -64.77%
2017 435.46%
2016 -38.43%
2015 N/A

Continue Researching PIRS

Want to see what other sources are saying about Pieris Pharmaceuticals Inc's financials and stock price? Try the links below:

Pieris Pharmaceuticals Inc (PIRS) Stock Price | Nasdaq
Pieris Pharmaceuticals Inc (PIRS) Stock Quote, History and News - Yahoo Finance
Pieris Pharmaceuticals Inc (PIRS) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7436 seconds.